Score Overview
Explore the 2021 public Archive ranking →
Where CONMED Corporation has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- CNMD
1996: 18.6% · 2021: 80.8% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 46.69 | — |
1 Year2025-09-29 | $ 45.67 | 2.23% |
5 Years2021-09-29 | $ 126.88 | -63.20% |
10 Years2016-09-29 | $ 35.97 | 29.80% |
20 Years2006-09-29 | $ 17.57 | 165.81% |
30 Years1996-09-27 | $ 9.98 | 367.60% |
All Time1987-07-23 | $ 1.91 | 24x |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | 30 Years1996-09-27 | All Time1987-07-23 |
|---|---|---|---|---|---|---|---|
| Price | $ 46.69 | $ 45.67 | $ 126.88 | $ 35.97 | $ 17.57 | $ 9.98 | $ 1.91 |
| Return | — | 2.23% | -63.20% | 29.80% | 165.81% | 367.60% | 24x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 1.37B | $ 56M | $ 37M |
| 2025 | $ 1.37B | $ 47M | $ 40M |
| 2024 | $ 1.30B | $ 132M | $ 24M |
| 2023 | $ 1.24B | $ 64M | $ 24M |
| 2022 | $ 1.04B | -$ 80M | $ 28M |
| 2021 | $ 1.01B | $ 62M | $ 20M |
| 2020 | $ 862M | $ 9M | $ 27M |
| 2019 | $ 955M | $ 28M | $ 25M |
| 2018 | $ 859M | $ 40M | $ 17M |
| 2017 | $ 796M | $ 55M | $ 32M |
| 2016 | $ 763M | $ 14M | $ 27M |
| 2015 | $ 719M | $ 30M | $ 72M |
| 2014 | $ 734M | $ 32M | $ 66M |
| 2013 | $ 756M | $ 35M | $ 54M |
| 2012 | $ 767M | $ 40M | $ 23M |
| 2011 | $ 725M | $ 752K | $ 26M |
| 2010 | $ 713M | $ 30M | $ 12M |
| 2009 | $ 694M | $ 12M | $ 9M |
| 2008 | $ 742M | $ 44M | $ 11M |
| 2007 | $ 694M | $ 41M | $ 11M |
| 2006 | $ 646M | -$ 12M | $ 3M |
| 2005 | $ 617M | $ 31M | $ 3M |
| 2004 | $ 558M | $ 33M | $ 4M |
| 2003 | $ 497M | $ 32M | $ 5M |
| 2002 | $ 453M | $ 34M | $ 5M |
| 2001 | $ 428M | $ 24M | $ 1M |
| 2000 | $ 392M | $ 19M | $ 3M |
| 1999 | $ 372M | $ 27M | $ 3M |
| 1998 | $ 336M | $ 17M | $ 5M |
| 1997 | $ 138M | -$ 7M | $ 13M |
| 1996 | $ 125M | $ 16M | $ 20M |
| 1995 | $ 99M | $ 10M | $ 1M |
| 1994 | $ 71M | $ 5M | |
| 1993 | $ 53M | -$ 1M | $ 2M |
| 1992 | $ 42M | $ 4M | $ 7M |
| 1991 | $ 38M | $ 3M | $ 4M |
| 1990 | $ 31M | $ 2M | $ 200K |
| 1989 | $ 19M | -$ 300K | $ 300K |
| 1988 | $ 14M | $ 800K | $ 2M |
| IPO1987 | $ 12M | $ 1M | $ 4M |
CONMED Corporation fundamental performance
Between 2020 and 2025, revenue grew from $ 862M to $ 1.37B and net income grew from $ 9M to $ 47M. Revenue increased in 4 of those 5 years; net income in 3.
Across CONMED Corporation's full reported history, from 1987 to 2025, revenue grew from $ 12M to $ 1.37B and net income grew from $ 1M to $ 47M. Revenue increased in 85% of the years measured; net income in 51%.
CONMED Corporation currently holds a 20-year HDB Score of 4.9 out of 10. How the HDB Score is calculated.
Membership
Continue CNMD’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
